Clinical Oncology - Issue 3/2024
Editorial
Reviews
Z. Adam, M. Hermanová, T. Horváth, L. Pour, S. Ševčíková, K. Starý, M. Dastych, Z. Řehák, Z. Adamová, Z. Král
I. Burešová, J. Halámková, I. Kiss, K. Kapounková, I. Hrnčiříková
A. Kaiglová, S. Kucharíková
Original Articles
H. A. Hirna, D. V. Maltsev, I. D. Kostyshyn, V. V. Holotiuk
V. Shivhare, S. Rath, I. B. Shah, N. K. Dash, A. Parikh, U. S. Kunikullaya
Case Reports
Z. Adam, Z. Řehák, M. Keřkovský, C. Povýšil, E. Ezer, A. Buliková, (ČHS), L. Pour, M. Doubek, Y. Stavařová, L. Zdražilová Dubská, P. Szutyany, S. Ševčíková, Z. Král
Oncology Highlights
A. Poprach, T. Büchler
Reports from the literature
Clinical Oncology
2024 Issue 3
Most read in this issue
- Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions – a case report and a literature review
- Overview of histiocytic and dendritic disorders by the 5th version of WHO Classifi cation of Hematolymphoid Tumours from 2022
- A novel approach to cancer screening using the nematode Caenorhabditis elegans-based detection assays
- Barriers and supportive factors in engaging cancer patients in physical activity programmes – a literature review